Company record
CataX AI
Updated · Presspool
CataX is an AI-native biotech that improves itself, sourcing drug assets and developing clinical proof of concept with agents. catax.bio
Funding
- RMB 40M Seed, announced November 16, 2026. Sole investor named: Qiming Venture Partners. Incubated by Qiming Venture Partners; legal name Shanghai Kaisida Biomedical Technology. Listed in the AI startup funding roster for November 16–21, 2026. Sources: TechNode, Sina Finance.
Whether AI names CataX AI
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to November 21, 2026.
Related records
Closest rounds in the roster for November 16–21, 2026: Metano ($12M Seed, November 19, 2026), Modern Industrials ($6M Seed, November 19, 2026), Wilgot (SEK 30M Seed, November 19, 2026), Perry AI ($2.2M Seed, November 18, 2026), Tesorai ($5.3M Seed, November 18, 2026), Unsiloed AI ($7.5M Seed, November 18, 2026).
Qiming Venture Partners, named as the sole investor in this round, led Lingchuan Technology (RMB 1 billion Series B, November 4, 2026).